Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis (2014)
- Authors:
- USP affiliated authors: DUARTE, ALBERTO JOSE DA SILVA - FM ; BENARD, GIL - FM
- Unidade: FM
- DOI: 10.2340/00015555-1650
- Subjects: PSORÍASE; DERMATOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Acta dermato-venereologica
- ISSN: 0001-5555
- Volume/Número/Paginação/Ano: v. 94, n. 1, p. 26-31, 2014
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
ORTIGOSA, Luciena Cegatto Martins et al. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, v. 94, n. 1, p. 26-31, 2014Tradução . . Disponível em: https://doi.org/10.2340/00015555-1650. Acesso em: 12 fev. 2026. -
APA
Ortigosa, L. C. M., Silva, L. C. R. da, Duarte, A. J. S., Takahashi, M. D. F., & Bebrad, G. (2014). Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, 94( 1), 26-31. doi:10.2340/00015555-1650 -
NLM
Ortigosa LCM, Silva LCR da, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2026 fev. 12 ] Available from: https://doi.org/10.2340/00015555-1650 -
Vancouver
Ortigosa LCM, Silva LCR da, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2026 fev. 12 ] Available from: https://doi.org/10.2340/00015555-1650 - Proliferative response to GP43, periodated GP43, and P. brasiliensis culture antigens in patients with or cured of paracoccidioidomycosis
- Expansion and suppressive capacity of regulatory T cells isolated from patients across the leprosy spectrum: a pilot study
- Different grades of IL-12p70 and IL-12 receptor Beta 2 expression characteriza the different clinical outcomes in paracoccidioidomycosis: role of IL-10
- Evaluation of P. brasiliensis phagocytosis by dentric cells of patients with Paracoccidioidomycosis and healthy individuals
- Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations
- Glycolipid Sensing and Innate Immunity in Paracoccidioidomycosis
- Evaluation of the in vitro anti-mycobacterium tuberculosis immunity in patients with moderate to severe psoriasis
- Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?
- Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area
- Immunological mechanisms implicated in recovery or development of acute or chronic forms of paracoccidioidomycosis (PCM).
Informações sobre o DOI: 10.2340/00015555-1650 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
